The Valley Desk

NCT02176863 · Interventional trial

Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio Syndrome

Overall registry status Terminated

Phase 2 · Phase 3

Conditions Post-polio Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov